West Des Moines, Iowa – November 21, 2025 – PRESSADVANTAGE –
Modern Vision Centers has released a new article titled “The Truth About EVO ICL and Glare: What Research Actually Shows,” addressing one of the most common questions patients have about implantable collamer lens (ICL) surgery—whether glare or halos after the procedure are significant or long-lasting. The publication offers a research-driven analysis of postoperative glare and visual perception outcomes, emphasizing transparency, data, and patient-centered care. Drawing on peer-reviewed studies and the practice’s own clinical observations, the article provides clarity for both patients and healthcare professionals seeking a deeper understanding of this widely discussed aspect of vision correction.
The report cites findings showing that while up to 30 percent of patients notice moderate glare during the initial weeks following EVO ICL surgery, these effects typically diminish within three months as neuroadaptation occurs. Modern Vision Centers notes that the glare experienced after EVO ICL is comparable to, or less persistent than, that seen in LASIK patients. The article also underscores that EVO ICL avoids reshaping the cornea—a factor that can reduce the risk of dry eye and other complications that sometimes exacerbate glare following laser-based procedures.
The piece explains that glare after ICL placement occurs due to the natural way light interacts with the intraocular lens and the patient’s eye anatomy. Factors such as pupil size and the central port design of the EVO ICL may initially cause light scatter, but advancements in lens optics, material composition, and surgical precision have substantially lowered these risks. The article describes how the use of high-quality Collamer material and UV-filtering technology improves visual acuity while maintaining biocompatibility with the human eye.
Modern Vision Centers emphasizes that improved surgical planning tools—such as corneal topography and wavefront analysis—have further reduced the likelihood of glare-related issues. These technologies allow surgeons to map the cornea and align the implant precisely with the patient’s visual axis, leading to optimal centration and lens positioning. The result, according to the article, is consistently clearer night vision and enhanced contrast sensitivity across a wide range of refractive errors.
According to the article, patients who undergo EVO ICL frequently report satisfaction with visual outcomes even when mild glare is present early on. Follow-up data indicate that most regain clear night vision within weeks and experience a high level of visual comfort compared to those reliant on glasses or contact lenses. The reversible and customizable nature of the ICL procedure adds another layer of reassurance, as adjustments can be made without altering the corneal structure. This flexibility distinguishes EVO ICL as a unique solution among refractive surgery options for individuals with high myopia, astigmatism, or thin corneas.
Dr. Drew Dickson, refractive surgeon at Modern Vision Centers, stated, “The purpose of this analysis was to address misconceptions and highlight the data showing that glare following EVO ICL is temporary for the vast majority of patients. With careful screening and modern surgical methods, we continue to see strong visual outcomes and exceptional long-term stability.”
The article also explores how Modern Vision Centers minimizes the likelihood of long-term glare through individualized preoperative evaluation. Each patient undergoes a comprehensive EyeAnalysis exam including refraction, corneal evaluation, and iris measurements to ensure proper lens sizing and placement. The team’s detailed approach allows for optimal vaulting of the lens over the eye’s natural crystalline lens, preventing tilt or decentration that could otherwise lead to visual disturbances.
By contrasting EVO ICL outcomes with those of LASIK and other procedures, the piece offers an evidence-based comparison that supports informed decision-making. Data show that while LASIK patients may experience longer-term glare, EVO ICL patients tend to adapt more quickly, with minimal impact on daily activities such as night driving. Modern Vision Centers’ findings mirror those seen in multiple global studies confirming EVO ICL’s excellent safety and satisfaction record.
The discussion concludes with a look toward the future of EVO ICL technology and glare reduction, noting ongoing improvements in lens design and manufacturing consistency. Continued refinement in both materials and surgical technique has contributed to a steady decline in reports of visual disturbances. As refractive surgery evolves, EVO ICL remains a leading option for those seeking high-definition vision without permanent alteration of corneal tissue.
The release of “The Truth About EVO ICL and Glare: What Research Actually Shows” underscores Modern Vision Centers’ commitment to transparency and patient education in ophthalmology. By addressing one of the most common concerns about ICL surgery with data-backed insights, the organization continues to strengthen its position as a trusted authority in advanced refractive care. Reporters and medical professionals interested in learning more about the findings or speaking with Modern Vision Centers’ surgical team may contact the practice directly for additional information.
###
For more information about Modern Vision Centers, contact the company here:
Modern Vision Centers
Jordan Maddox
(515) 674-2020
jmaddexkopp@aligned.vision
6880 EP True Pkwy Suite 110, West Des Moines, IA 50266
